Physician profile
Christopher Mantle
NPI 1104973924
$1,110.80
in general payments reported to CMS, 2019-2025
17 companies · $443 in 2025
The $443 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.63 · 2021: $151 · 2022: $135 · 2023: $75.09 · 2024: $291 · 2025: $443.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $809.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $808.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $260.75 | 2023-2025 | Dupixent |
| Optinose US, INC. | $240.40 | 2021-2025 | |
| Genzyme Corporation | $156.39 | 2023-2025 | |
| Stryker Corporation | $108.39 | 2021-2022 | |
| Abbvie INC. | $59.42 | 2024 | |
| Alk-Abello, INC | $51.12 | 2021 | |
| Merck Sharp & Dohme LLC | $31.46 | 2025 | Keytruda |
| Integra Lifesciences Corporation | $26.65 | 2025 | Codman Isocool Aht, Microfrance, Integra Duo |
| Neurent Medical Limited | $24.78 | 2022 | |
| Genentech USA, INC. | $23.09 | 2022 | |
| Hologic Sales and Service, LLC | $22.88 | 2023 | Coolseal Generator |
| Inspire Medical Systems, INC. | $21.20 | 2025 | Inspire |
| Ars Pharmaceuticals Operations, INC. | $19.73 | 2025 | Neffy |
| Phadia US INC. | $16.72 | 2022 | |
| Olympus America INC. | $16.63 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $15.78 | 2025 | Nucala |
| Lilly USA, LLC | $15.41 | 2025 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Mantle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.